Published • loading... • Updated
Luxembourg - Linklaters Advises Redalpine On Helical’s New Fundraising Round To Accelerate AI-driven Drug Discovery.
Summary by Conventus Law
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Luxembourg - Linklaters Advises Redalpine On Helical’s New Fundraising Round To Accelerate AI-driven Drug Discovery.
Linklaters has advised redalpine, a leading multi-stage venture capital investor, as lead investor on the fundraising of Helical, a Luxembourg-based start-up developing a virtual artificial intelligence (AI) laboratory designed to speed up and improve the reliability of drug discovery, alongside a syndicate of international investors. Headquartered in Luxembourg and co-founded by three Luxembourgish entrepreneurs, Helical aims to build a virtual…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
